See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $159B | 0.4x | 10.0x | |
| $38.6B | 0.2x | 10.1x | |
| $24.7B | 7.2x | 30.1x | |
| $20.2B | 2.2x | 46.2x | |
| $10.6B | 2.4x | 42.0x | |
| $7.6B | 1.1x | 10.7x | |
| $7.6B | 0.2x | 3.4x | |
| $7.3B | 0.9x | 11.6x | |
| $6.9B | 0.6x | 11.6x | |
| $5.3B | 1.9x | 14.4x | |
| $5.0B | 0.7x | 11.6x | |
| $4.5B | 0.7x | 10.2x | |
| $4.2B | 1.6x | 9.4x | |
| $3.9B | 0.2x | 5.4x | |
| $3.6B | 0.6x | 8.4x | |
| $3.6B | 1.0x | 9.3x | |
| $3.6B | 0.4x | 8.2x | |
| $3.5B | 0.5x | 8.2x | |
| $3.0B | 0.9x | 11.4x | |
| $2.7B | 0.7x | 7.1x | |
| $2.6B | 0.4x | 5.0x | |
| $2.4B | 0.7x | 6.8x | |
| $2.2B | 0.7x | 35.8x | |
| $2.0B | 1.1x | 8.2x | |
| $2.0B | 0.8x | 10.2x | |
| $1.7B | 2.2x | 6.9x | |
| $1.5B | 0.4x | 6.4x | |
| $1.5B | 1.3x | 11.1x | |
| $1.3B | 0.4x | n/a | |
| $1.2B | 1.7x | 20.5x | |
| $1.2B | 0.5x | 12.7x | |
| $1.2B | 0.8x | 10.4x | |
| $1.1B | n/a | n/a | |
| $1.1B | n/a | n/a | |
| $1.1B | 0.4x | 6.9x | |
| $993M | n/a | n/a | |
| $844M | n/a | n/a | |
| $837M | 1.4x | 15.5x | |
| $690M | 0.3x | 26.0x | |
| $689M | n/a | n/a | |
| $689M | n/a | n/a | |
| $650M | n/a | n/a | |
| $511M | 0.4x | -9.3x | |
| $458M | 0.5x | 6.1x | |
| $417M | n/a | n/a | |
| $303M | 0.7x | 12.4x | |
| $288M | 0.1x | n/a | |
| $278M | n/a | n/a | |
| $154M | n/a | n/a | |
| $92.8M | n/a | n/a | |
| $84.6M | 0.6x | 23.4x | |
| $52.8M | n/a | n/a | |
| $26.4M | n/a | n/a | |
| $25.7M | 0.3x | 53.9x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies